In the article entitled, “Toward Routine Use of 3D Histopathology as a Research Tool” (Volume 180, pages 1835–1842 of the May 2012 issue of The American Journal of Pathology), the support footnote should have included the following: “This work was partially funded through WELMEC, a Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (grant WT088908/Z/09/Z ).”
In the April 2012 This Month in AJP feature (Volume 180, page 1333) highlighting “Amyloid Precursor Protein Is a Biomarker for Transformed Human Pluripotent Stem Cells,” the first author's name was misspelled. The correct surname is Venkataramani.
In the article entitled, “ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome” (Volume 180, pages 1159–1169 of the March 2012 issue), the location of the National Defense Medical Center was incorrectly listed in the author affiliations and in the Acknowledgments. The correct affiliation is National Defense Medical Center, Taipei, Taiwan.
In the article entitled, “Loss of Msx2 Function Down-Regulates the FoxE3 Expression and Results in Anterior Segment Dysgenesis Resembling Peters Anomaly” (Volume 180, pages 2230-2239 of the June 2012 issue), details for reprint requests were included, but the corresponding author's contact information was inadvertently omitted. Please address correspondence to Jinsong Zhang, M.D., Eye Hospital of China Medical University, Department of Ophthalmology, the 4th Affiliated Hospital of China Medical University, Provincial Key Laboratory of Lens Research, Liaoning, China 110005. E-mail: email@example.com .
© 2012 American Society for Investigative Pathology. Published by Elsevier Inc.